Affiliations
AffiliationsItem in Clipboard
Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018Reinier G S Meester et al. Cancer. 2015.
. 2015 Jul 1;121(13):2281-5. doi: 10.1002/cncr.29336. Epub 2015 Mar 12. AffiliationsItem in Clipboard
AbstractBackground: The National Colorectal Cancer Roundtable, a national coalition of public, private, and voluntary organizations, has recently announced an initiative to increase colorectal cancer (CRC) screening rates in the United States to 80% by 2018. The authors evaluated the potential public health benefits of achieving this goal.
Methods: The authors simulated the 1980 through 2030 United States population of individuals aged 50 to 100 years using microsimulation modeling. Test-specific historical screening rates were based on National Health Interview Survey data for 1987 through 2013. The effects of increasing screening rates from approximately 58% in 2013 to 80% in 2018 were compared to a scenario in which the screening rate remained approximately constant. The outcomes were cancer incidence and mortality rates and numbers of CRC cases and deaths during short-term follow-up (2013-2020) and extended follow-up (2013-2030).
Results: Increasing CRC screening rates to 80% by 2018 would reduce CRC incidence rates by 17% and mortality rates by 19% during short-term follow-up and by 22% and 33%, respectively, during extended follow-up. These reductions would amount to a total of 277,000 averted new cancers and 203,000 averted CRC deaths from 2013 through 2030.
Conclusions: Achieving the goal of increasing the uptake of CRC screening in the United States to 80% by 2018 may have a considerable public health impact by averting approximately 280,000 new cancer cases and 200,000 cancer deaths within <20 years. Cancer 2015;121:2281-2285. © 2015 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Keywords: cancer screening; colorectal neoplasms; incidence; mortality; public health.
© 2015 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society.
FiguresFigure 1
Crude colorectal cancer ( Top…
Figure 1
Crude colorectal cancer ( Top ) incidence and ( Bottom ) mortality rates…
Figure 1Crude colorectal cancer (Top) incidence and (Bottom) mortality rates in the US population aged ≥50 years, under 2 scenarios of screening uptake. In the first scenario, reported screening rates remained at a constant level of approximately 60% from 2013 through 2030, whereas in the other scenario, screening rates increased from 60% to 80% by 2018 and remained constant thereafter.
Similar articlesFedewa SA, Ma J, Sauer AG, Siegel RL, Smith RA, Wender RC, Doroshenk MK, Brawley OW, Ward EM, Jemal A. Fedewa SA, et al. Cancer. 2015 Dec 1;121(23):4258-65. doi: 10.1002/cncr.29659. Epub 2015 Aug 26. Cancer. 2015. PMID: 26308967
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2010 Jul 9;59(26):808-12. MMWR Morb Mortal Wkly Rep. 2010. PMID: 20613704
Meester RG, Doubeni CA, Lansdorp-Vogelaar I, Goede SL, Levin TR, Quinn VP, Ballegooijen Mv, Corley DA, Zauber AG. Meester RG, et al. Ann Epidemiol. 2015 Mar;25(3):208-213.e1. doi: 10.1016/j.annepidem.2014.11.011. Epub 2014 Dec 5. Ann Epidemiol. 2015. PMID: 25721748 Free PMC article.
Verma M, Sarfaty M, Brooks D, Wender RC. Verma M, et al. CA Cancer J Clin. 2015 Nov-Dec;65(6):497-510. doi: 10.3322/caac.21295. Epub 2015 Sep 1. CA Cancer J Clin. 2015. PMID: 26331705 Review.
Simon K. Simon K. Clin Interv Aging. 2016 Jul 19;11:967-76. doi: 10.2147/CIA.S109285. eCollection 2016. Clin Interv Aging. 2016. PMID: 27486317 Free PMC article. Review.
Şahin MK, Aker S. Şahin MK, et al. J Cancer Educ. 2017 Dec;32(4):908-913. doi: 10.1007/s13187-016-1047-9. J Cancer Educ. 2017. PMID: 27193411
Sharma KP, Grosse SD, Maciosek MV, Joseph D, Roy K, Richardson LC, Jaffe H. Sharma KP, et al. Prev Chronic Dis. 2020 Oct 8;17:E123. doi: 10.5888/pcd17.200039. Prev Chronic Dis. 2020. PMID: 33034556 Free PMC article.
Murphy CC, Sandler RS, Sanoff HK, Yang YC, Lund JL, Baron JA. Murphy CC, et al. Clin Gastroenterol Hepatol. 2017 Jun;15(6):903-909.e6. doi: 10.1016/j.cgh.2016.08.037. Epub 2016 Sep 5. Clin Gastroenterol Hepatol. 2017. PMID: 27609707 Free PMC article.
Levin TR, Corley DA, Jensen CD, Schottinger JE, Quinn VP, Zauber AG, Lee JK, Zhao WK, Udaltsova N, Ghai NR, Lee AT, Quesenberry CP, Fireman BH, Doubeni CA. Levin TR, et al. Gastroenterology. 2018 Nov;155(5):1383-1391.e5. doi: 10.1053/j.gastro.2018.07.017. Epub 2018 Jul 19. Gastroenterology. 2018. PMID: 30031768 Free PMC article.
Loomans-Kropp HA, Umar A. Loomans-Kropp HA, et al. J Cancer Epidemiol. 2019 Nov 11;2019:9841295. doi: 10.1155/2019/9841295. eCollection 2019. J Cancer Epidemiol. 2019. PMID: 31827515 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3